Chardan Capital Has Strong Forecast for STOK FY2025 Earnings
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities researchers at Chardan Capital raised their FY2025 earnings per share (EPS) estimates for Stoke Therapeutics in a research report issued to clients and investors on Wednesday, May 14th. Chardan Capital analyst R. Li now anticipates that the company will post earnings of $0.45 per share for […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities researchers at Chardan Capital raised their FY2025 earnings per share (EPS) estimates for Stoke Therapeutics in a research report issued to clients and investors on Wednesday, May 14th. Chardan Capital analyst R. Li now anticipates that the company will post earnings of $0.45 per share for […]
